News & Perspective

Sep 14, 2017

Sep 14, 2017

News Scan for Sep 14, 2017

Flu vaccines and birth outcomes
Mixed results for malaria vaccine
Avian flu outbreaks
Vaccines and autism
Viruses in semen

May 22, 2017

May 22, 2017
WHA Margaret Chan

WHA hears Chan's farewell, prepares to pick new WHO head

Chan said infectious disease challenges over the last decade led to better preparedness, but not nearly enough.

May 18, 2017

May 18, 2017

News Scan for May 18, 2017

Singapore Zika lessons
Novel H7N2 virulence
Clinical trial reporting standards

Aug 21, 2015

Aug 21, 2015

News Scan for Aug 21, 2015

NY Legionella source
H5N6 in Vietnam
C diff virulence
Jamboree-linked meningococcal disease outbreak
Airborne spread of swine viruses

Apr 25, 2013

Apr 25, 2013

Study: Lab-derived H5N1 virus component binds to human receptors

(CIDRAP News) – A new study suggests that a lab-derived hybrid H5N1 influenza virus that is capable of airborne transmission among ferrets may well be capable of doing the same thing in humans.

Jul 29, 2011

Jul 29, 2011

Study: Antibody binds to all influenza A subtypes

(CIDRAP News) – A team of European researchers reported yesterday the discovery of a human monoclonal antibody that binds to all types of influenza A viruses, raising the prospect of a new flu treatment and improving the chances of developing a broadly protective or "universal" flu vaccine.

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Oct 26, 2007

Oct 26, 2007

THE PANDEMIC VACCINE PUZZLE Part 2: Vaccine production capacity falls far short

Editor's note: This is the second in a seven-part series investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts promising advances in vaccine technology in perspective by illuminating the formidable barriers to producing large amounts of an effective and widely usable vaccine in a short time frame.

Aug 16, 2007

Aug 16, 2007

Glaxo sells more H5N1 vaccine to US, launches trial

(CIDRAP News) – The British pharmaceutical company GlaxoSmithKline (GSK) recently announced another major order of prepandemic H5N1 influenza vaccine from the US Department of Health and Human Services (HHS), along with plans to launch a North American clinical trial of the vaccine.

Apr 11, 2006

Apr 11, 2006

Avian flu in Myanmar concerns FAO

(CIDRAP News) – Avian influenza is continuing its spread among birds in many countries worldwide, with widespread outbreaks reported in Myanmar.

More than 100 outbreaks have occurred in poultry in Myanmar (formerly Burma) since the presence of H5N1 avian flu was announced there about a month ago, officials from the United Nations Food and Agriculture Organization (FAO) told Reuters news service yesterday.

Pages

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»